STARTUP PROFILE

Fisher Wallace Labs

COUNTRY
USA
FOUNDED
2007
CATEGORY
Neuromodulation
Offering an FDA-cleared cranial electrotherapy stimulator that non-invasively treats depression, anxiety, and insomnia via home use.
Visit website →
Neurofounders Insights
$   Funding   -
Non-dilutive
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Psychiatry
TARGET USER
Patients
REGULATORY STAGE
Investigational
Fisher Wallace Labs is a long-standing player in cranial electrotherapy stimulation, offering home-use devices for depression and anxiety. Its regulatory pathway and consumer accessibility drive adoption, though clinical efficacy debates persist.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Fisher Wallace Labs
No items found.